One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Editorial Board/Officer's Page
doi : 10.1016/S1936-8798(23)00640-4
Volume 16, Issue 8, 24 April 2023, Pages A1-A4
Instructions for Authors
doi : 10.1016/S1936-8798(23)00706-9
Volume 16, Issue 8, 24 April 2023, Pages A5-A13
Emerging Approaches to Management of Left Ventricular Outflow Obstruction Risk in Transcatheter Mitral Valve Replacement
Mackram F. Eleid, MD, a Jeremy D. Collins, MD, b Paul Mahoney, MD, c Eric E. Williamson, MD,b Ammar M. Killu, MBBS,a Brian K. Whisenant, MD, d Charanjit S. Rihal, MD, MBA, a Mayra E. Guerrero, MD
doi : 10.1016/j.jcin.2023.01.357
Volume 16, Issue 8, 24 April 2023, Pages 885-895
An increasing number of patients with mitral valve disease are high risk for surgery and in need of less invasive treatments including transcatheter mitral valve replacement (TMVR). Left ventricular outflow tract (LVOT) obstruction is a predictor of poor outcome after TMVR, and its risk can be accurately predicted using cardiac computed tomography analysis.
Impact of Transcatheter Edge-to-Edge Mitral Valve Repair on Guideline-Directed Medical Therapy Uptitration
Marianna Adamo, MD,a, * Daniela Tomasoni, MD,a, * Lukas Stolz, MD,b Thomas J. Stocker, MD,b Edoardo Pancaldi, MD, a Benedikt Koell, MD, c Nicole Karam, MD,d Christian Besler, MD, e Cristina Giannini, MD, f Francisco Sampaio, MD,g Fabien Praz, MD,h Tobias Ruf, MD,i Louis Pechmajou, MD, d Michael Neuss, MD, j Christos Iliadis, MD,k Stephan Baldus, MD,k Christian Butter, MD, j Daniel Kalbacher, MD, c Philipp Lurz, MD,e Bruno Melica, MD,g Anna S. Petronio, MD, f Ralph Stephan von Bardeleben, MD,i Stephan Windecker, MD,h Javed Butler, MD,l Gregg C. Fonarow, MD,m Jörg Hausleiter, MD, b,y Marco Metra, MD
doi : 10.1016/j.jcin.2023.01.362
Volume 16, Issue 8, 24 April 2023, Pages 896-905
Guideline-directed medical therapy (GDMT) optimization is mandatory before transcatheter edge-to-edge mitral valve repair (M-TEER) in patients with secondary mitral regurgitation (SMR) and heart failure (HF) with reduced ejection fraction (HFrEF). However, the effect of M-TEER on GDMT is unknown.
Optimizing Outcomes After Transcatheter Mitral Valve Repair: The Case for Maximizing Medical Therapy∗
David W.M. Muller, MBBS, MD
doi : 10.1016/j.jcin.2023.02.023
Volume 16, Issue 8, 24 April 2023, Pages 906-908
Sex-Related Differences in Clinical Characteristics and Outcome Prediction Among Patients Undergoing Transcatheter Tricuspid Valve Intervention
Vera Fortmeier, MD,a, * Mark Lachmann, MD,b,c, * Maria I. Körber, MD,d Matthias Unterhuber, MD, e Anne R. Schöber, MD, e Lukas Stolz, MD, f Thomas J. Stocker, MD, c,f Mohammad Kassar, MD, g Muhammed Gerçek, MD, a Tanja K. Rudolph, MD,a Fabien Praz, MD,g Stephan Windecker, MD,g Roman Pfister, MD, d Stephan Baldus, MD, d Karl-Ludwig Laugwitz, MD, b,c Jörg Hausleiter, MD, c,f Philipp Lurz, MD, e Volker Rudolph, MD
doi : 10.1016/j.jcin.2023.01.378
Volume 16, Issue 8, 24 April 2023, Pages 909-923
Men and women differ regarding comorbidities, pathophysiology, and the progression of valvular heart diseases.
Sex and TTVI: Equality in Efficacy∗
Georg Nickenig, MD, Atsushi Sugiura, MD, PHD
doi : 10.1016/j.jcin.2023.02.035
Volume 16, Issue 8, 24 April 2023, Pages 924-926
Explant vs Redo-TAVR After Transcatheter Valve Failure: Mid-Term Outcomes From the EXPLANTORREDO-TAVR International Registry
Gilbert H.L. Tang, MD, MS C, MBA, a, * Syed Zaid, MD, b, * Neal S. Kleiman, MD, b Sachin S. Goel, MD,b Shinichi Fukuhara, MD, c Mateo Marin-Cuartas, MD,d Philipp Kiefer, MD, d Mohamed Abdel-Wahab, MD,d Ole De Backer, MD, e Lars Søndergaard, MD,e Shekhar Saha, MD, f Christian Hagl, MD,g Moritz Wyler von Ballmoos, MD, PH D, MPH,b Oliver Bhadra, MD, h Lenard Conradi, MD,h Kendra J. Grubb, MD, MHA,
doi : 10.1016/j.jcin.2023.01.376
Volume 16, Issue 8, 24 April 2023, Pages 927-941
Valve reintervention after transcatheter aortic valve replacement (TAVR) failure has not been studied in detail.
Redo Surgical Aortic Valve Replacement After Prior Transcatheter Versus Surgical Aortic Valve Replacement
Robert B. Hawkins, MD, MSC ,a,b G. Michael Deeb, MD,a,b Devraj Sukul, MD, MS C,a,b Himanshu J. Patel, MD, a,b Sarah K. Gualano, MD,a,b Stanley J. Chetcuti, MD,a,b P. Michael Grossman, MD, a,b Gorav Ailawadi, MD, MBA, a,b Shinichi Fukuhara, MD
doi : 10.1016/j.jcin.2023.03.015
Volume 16, Issue 8, 24 April 2023, Pages 942-953
Aortic stenosis treatment should consider risks and benefits for lifetime management. Although the feasibility of redo transcatheter aortic valve replacement (TAVR) remains unclear, concerns are emerging regarding reoperation after TAVR.
Redo Aortic Valve Interventions: A Good Start Is Half the Job to Subsequent Permutations∗
Giuseppe Tarantini, MD, PHD, Tommaso Fabris, MD
doi : 10.1016/j.jcin.2023.03.014
Volume 16, Issue 8, 24 April 2023, Pages 954-957
Prevalence and Predictors of Cardiogenic Shock in Intermediate-Risk Pulmonary Embolism: Insights From the FLASH Registry
Sripal Bangalore, MD, MHA, a James M. Horowitz, MD, b Daren Beam, MD, c Wissam A. Jaber, MD, d Sameer Khandhar, MD, e Catalin Toma, MD, f Mitchell D. Weinberg, MD, MBA, g Bushra Mina, MD h
doi : 10.1016/j.jcin.2023.02.004
Volume 16, Issue 8, 24 April 2023, Pages 958-972
Patients with acute pulmonary embolism (PE) and hypotension (high-risk PE) have high mortality. Cardiogenic shock can also occur in nonhypotensive or normotensive patients (intermediate-risk PE) but is less well characterized.
Identifying Normotensive Shock: A FLASH Forward in Acute Pulmonary Embolism Care?∗
Geoffrey D. Barnes, MD, MSC ,a Amber Liles, MD
doi : 10.1016/j.jcin.2023.03.017
Volume 16, Issue 8, 24 April 2023, Pages 973-975
Periprocedural Complications With Balloon Pulmonary Angioplasty: Analysis of Global Studies
Nishant Jain, MD,a Muhammad A. Sheikh, MD,b Divyansh Bajaj, MD,c Whitney Townsend, BA, d Richard Krasuski, MD,e Eric Secemsky, MD, f Saurav Chatterjee, MD,g Victor Moles, MD, h Prachi P. Agarwal, MD, MS, i Jonathan Haft, MD, j Scott H. Visovatti, MD, k Thomas M. Cascino, MD, MS C,h Kenneth Rosenfield, MD,l Brahmajee K. Nallamothu, MD, h,m Vallerie V. Mclaughlin, MD,h Vikas Aggarwal, MD, MPH
doi : 10.1016/j.jcin.2023.01.361
Volume 16, Issue 8, 24 April 2023, Pages 976-983
Time to Standardize Definitions for the Success and Complications of Balloon Pulmonary Angioplasty: A Quality Imperative∗
Ehtisham Mahmud, MD, Lawrence Ang, MD
doi : 10.1016/j.jcin.2023.02.017
Volume 16, Issue 8, 24 April 2023, Pages 984-985
Bailout Strategy for Pulmonary Artery Rupture With a Gelatin Sponge in Balloon Pulmonary Angioplasty
Ryosuke Ito, MD, PH D, Jun Yamashita, MD, PHD, Yuki Nakajima, MD, Taishiro Chikamori, MD, PH D
doi : 10.1016/j.jcin.2022.12.013
Volume 16, Issue 8, 24 April 2023, Pages 986-987
Percutaneous Debulking of Pulmonary Prosthetic Valve Endocarditis Using Intracardiac Echocardiographic Guidance
Pradyumna Agasthi, MD,a Frank Cetta, MD,a,b Jason H. Anderson, MD a,b
doi : 10.1016/j.jcin.2023.01.021
Volume 16, Issue 8, 24 April 2023, Pages 988-990
Direct, Transapical, Scissors-Mediated LAMPOON: Keeping it Simple!
Efstratios I. Charitos, MD, P HD, a,b Nikolai Busch, MD, b Matthias Renker, MD, b Oliver J. Liakopoulos, MD, PHD, a Ulrich Fischer-Rasokat, MD, PHD, b Andrea Colli, MD, PHD, c Christian W. Hamm, MD, P HD, b,d Yeong-Hoon Choi, MD, PH D, a Won-Keun Kim, MD, PHD
doi : 10.1016/j.jcin.2022.12.014
Volume 16, Issue 8, 24 April 2023, Pages 991-992
Exfoliated Intima Wrapping the Prosthetic Valve During Transcatheter Tricuspid Valve Replacement
Fei Chen, MD,a, * Hong Qian, MD, b, * Zhengang Zhao, MD,a Xin Wei, MD, a Xi Li, MD, a Yuan Feng, MD, a Wei Meng, MD,b Mao Chen, MD, P HD
doi : 10.1016/j.jcin.2023.01.009
Volume 16, Issue 8, 24 April 2023, Pages 993-996
Variation of the Appearance of Intraplaque Hemorrhage on Optical Coherence Tomography and Intravascular Ultrasound
Takeshi Nishi, MD, PHD, Teruyoshi Kume, MD, P HD, Ryotaro Yamada, MD, P HD, Yoji Neishi, MD, PHD, Shiro Uemura, MD, PHD
doi : 10.1016/j.jcin.2023.01.370
Volume 16, Issue 8, 24 April 2023, Pages 997-999
Risk of Selection Bias in Observational Comparative Research on Left Main Revascularization Strategies
Alfredo MatÃas Rodriguez-Granillo, MD Carolina Salvatori, MD Fabricio Gastón Procopio, MD Giuseppe Biondi-Zoccai, MD, MStat on behalf of the Counsil of Clinical and Therapeutical Cardiology from de Argentinian Society of Cardiology (SAC)
doi : 10.1016/j.jcin.2023.02.032
Volume 16, Issue 8, 24 April 2023, Page 1000
Reply: Risk of Selection Bias in Observational Comparative Research on Left Main Revascularization Strategies
Derrick Y. Tam, MD, PhD Rodolfo V. Rocha, MD, PhD Stephen E. Fremes, MD, MSc *Douglas S. Lee, MD, PhD
doi : 10.1016/j.jcin.2023.03.031
Volume 16, Issue 8, 24 April 2023, Page 1001
Pitfalls of Simplifying the Original SYNTAX Score: A Temptation That Should Be Resisted
Shigetaka Kageyama, MD Yoshinobu Onuma, MD Scot Garg, MD *Patrick W. Serruys, MD
doi : 10.1016/j.jcin.2023.02.024
Volume 16, Issue 8, 24 April 2023, Pages 1002-1003
Reply: Pitfalls of Simplifying the Original SYNTAX Score: A Temptation That Should Be Resisted
Christopher P. Kovach, MD, MSc Javier A. Valle, MD, MSCS *Stephen W. Waldo, MD
doi : 10.1016/j.jcin.2023.03.006
Volume 16, Issue 8, 24 April 2023, Page 1004
Clinical Outcomes of PASCAL Compared With the MitraClip for Symptomatic Mitral Regurgitation: A Meta-Analysis
Agam Bansal, MD Mohammed Faisaluddin, MD Siddharth Agarwal, MD Osamah Badwan, MD Serge C. Harb, MD Amar Krishnaswamy, MD Marc Gillinov, MD *Samir R. Kapadia, MD
doi : 10.1016/j.jcin.2023.01.355
Volume 16, Issue 8, 24 April 2023, Pages 1005-1007
Hemodynamic Profiling of Patients Undergoing Transcatheter Mitral Edge-to-Edge Repair
Alejandra Chavez Ponce, MD* Sahar Samimi, MD* Ahmed El Shaer, MBBS Samian Sulaiman, MD Mackram F. Eleid, MD Mayra Guererro, MD Jeremy Thaden, MD Charanjit S. Rihal, MD yMohamad Alkhouli, MD
doi : 10.1016/j.jcin.2023.01.379
Volume 16, Issue 8, 24 April 2023, Pages 1008-1009
Full Issue PDF
doi : 10.1016/S1936-8798(23)00704-5
Volume 16, Issue 8, 24 April 2023, Pages I-CXXXVIII
